CFG
XBI icon

Carter Financial Group’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Carter Financial Group’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,917
Closed -$245K – 143
2026
Q1 		$245K Hold
1,917
– – 0.15% 101
2025
Q4 		$234K Buy
+1,917
New +$220K 0.14% 105

Other funds holding XBI

MSR
Main Street Research Lakeville, Connecticut $2.12B AUM 67.44% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $188M AUM
AssetMark Inc
AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return
SO
STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return
WT
Whittier Trust South Pasadena, California $10.2B AUM 33.39% 1-Year Est. Return
AAS
Annex Advisory Services Brookfield, Wisconsin $5.86B AUM 21.83% 1-Year Est. Return
WAM
Weatherly Asset Management Del Mar, California $1.4B AUM 36.32% 1-Year Est. Return
RFM
Royal Fund Management Lady Lake, Florida $1.2B AUM 32.21% 1-Year Est. Return
NHFG
New Harbor Financial Group Worcester, Massachusetts $633M AUM 37.53% 1-Year Est. Return
RAM
Riggs Asset Management Dallas, Pennsylvania $560M AUM 64.94% 1-Year Est. Return

Carter Financial Group's XBI Position: Q2 2026 in Review

Carter Financial Group sold out of State Street SPDR S&P Biotech ETF (XBI) in Q2 2026, closing a stake of 1,917 shares — an estimated $245K sold.

Carter Financial Group first reported a position in XBI in Q4 2025 and held it in 2 quarters. The position peaked at $245K in Q1 2026. 393 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

  • Carter Financial Group reported no remaining State Street SPDR S&P Biotech ETF position as of Q2 2026 after selling out during the quarter.
  • Carter Financial Group sold 1,917 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $245K.
  • Carter Financial Group first reported a position in State Street SPDR S&P Biotech ETF in Q4 2025 and held it in 2 quarters.
  • Carter Financial Group's State Street SPDR S&P Biotech ETF position peaked at $245K in Q1 2026.
  • 393 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Carter Financial Group's 13F filing for Q2 2026, filed 30 Jul 2026.